Young Li
Stock Analyst at Jefferies
(0.88)
# 3,994
Out of 5,148 analysts
8
Total ratings
60%
Success rate
-13.49%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Maintains: Buy | $28 → $22 | $19.05 | +12.86% | 1 | Jan 28, 2026 | |
| TMDX TransMedics Group | Initiates: Buy | $145 | $147.00 | -1.36% | 1 | Oct 13, 2025 | |
| RXST RxSight | Downgrades: Hold | $24 → $9 | $7.61 | +18.27% | 2 | Jul 10, 2025 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $83.92 | +37.04% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $1.06 | +17.92% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $25.70 | +133.46% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $14.32 | +221.23% | 1 | Jul 16, 2021 |
STAAR Surgical Company
Jan 28, 2026
Maintains: Buy
Price Target: $28 → $22
Current: $19.05
Upside: +12.86%
TransMedics Group
Oct 13, 2025
Initiates: Buy
Price Target: $145
Current: $147.00
Upside: -1.36%
RxSight
Jul 10, 2025
Downgrades: Hold
Price Target: $24 → $9
Current: $7.61
Upside: +18.27%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $83.92
Upside: +37.04%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $1.06
Upside: +17.92%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $25.70
Upside: +133.46%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $14.32
Upside: +221.23%